Skip to content
Home/Companies/Pharma/Axience
Axience

Axience

Pharma·France·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Axience?

Axience is a French Pharma company, currently owned by Motion Equity Partners since 2024.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Motion Equity Partners
Investor
Motion Equity Partners
Motion Equity Partners Fund · 2024 · Buyout

Key facts

HQFrance
SectorPharma
Websitewww.axience.fr

More from Motion Equity Partners Fund

Other portfolio companies in the same fund.

Polaris
Polaris
Active
SaaSFrance· 2026
Sileane
Active
IndustrialsFrance· 2025
Siléane
Siléane
Active
IndustrialsFrance· 2025
Banook
Banook
Active
MedTechFrance· 2024
Tournaire
Tournaire
Active
IndustrialsFrance· 2023
Résilians
Active
ConstructionFrance· 2021

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Axience?

Axience is currently owned by Motion Equity Partners, through Motion Equity Partners Fund, since 2024.

When did Motion Equity Partners acquire Axience?

Motion Equity Partners acquired Axience in 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue